Expression of the 17-1A antigen in gastric and gastro-oesophageal junction adenocarcinomas: a potential immunotherapeutic target?

199916 citationsJournal Articlebronze Open Access

Authors

Abstract

The high incidence of expression of the 17-1A antigen in patients with gastric and gastro-oesophageal junction adenocarcinomas suggests a potential role for these antibodies as an adjuvant treatment for these common cancers.

Topics & Keywords

Gastric Cancer Management and Outcomes Esophageal Cancer Research and Treatment Gastrointestinal Tumor Research and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Pathology

Volume 52, Issue 9, pp. 701-704

DOI: 10.1136/jcp.52.9.701

Field-Weighted Citation Impact: 0.81